What Sangamo Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 2 |
| Total trades | 0 | 29 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 763,420 |
| Net activity | +0 | −763,420 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | May 25 | Withheld — tax / exercise cost · F | −12,613 | $0.17 | −$2.2K | 1,895,043 |
| Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | May 25 | Withheld — tax / exercise cost · F | −4,036 | $0.17 | −$703 | 647,370 |
| Dubois-Stringfellow Nathalie | SVP-CHIEF DEVELOPMENT OFFICER | May 25 | Withheld — tax / exercise cost · F | −4,036 | $0.17 | −$703 | 328,733 |
| Jain Nikunj | Principal Accounting Officer | May 25 | Withheld — tax / exercise cost · F | −1,919 | $0.17 | −$334 | 235,292 |
| Davis Gregory D | Head of Research & Technology | May 25 | Withheld — tax / exercise cost · F | −1,630 | $0.17 | −$284 | 113,654 |
| Davis Gregory D | Head of Research & Technology | Apr 22 | Open-market sale · S | −69,827 | $0.25 | −$17.7K | 115,284 |
| Dubois-Stringfellow Nathalie | SVP-CHIEF DEVELOPMENT OFFICER | Apr 21 | Open-market sale · S | −345,942 | $0.26 | −$89.2K | 332,769 |
| Davis Gregory D | Head of Research & Technology | Feb 25 | Withheld — tax / exercise cost · F | −5,119 | $0.47 | −$2.41K | 185,111 |
| Jain Nikunj | Principal Accounting Officer | Feb 25 | Withheld — tax / exercise cost · F | −5,119 | $0.47 | −$2.41K | 237,211 |
| Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | Feb 25 | Withheld — tax / exercise cost · F | −12,354 | $0.47 | −$5.81K | 651,406 |
| Dubois-Stringfellow Nathalie | SVP-CHIEF DEVELOPMENT OFFICER | Feb 25 | Withheld — tax / exercise cost · F | −12,354 | $0.47 | −$5.81K | 678,711 |
| Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | Feb 25 | Withheld — tax / exercise cost · F | −33,637 | $0.47 | −$15.8K | 1,907,656 |
| Davis Gregory D | Head of Research & Technology | Feb 24 | Withheld — tax / exercise cost · F | −832 | $0.47 | −$393 | 190,230 |
| Jain Nikunj | Principal Accounting Officer | Feb 24 | Withheld — tax / exercise cost · F | −666 | $0.47 | −$315 | 242,330 |
| Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | Feb 24 | Withheld — tax / exercise cost · F | −1,650 | $0.47 | −$780 | 663,760 |
| Dubois-Stringfellow Nathalie | SVP-CHIEF DEVELOPMENT OFFICER | Feb 24 | Withheld — tax / exercise cost · F | −2,063 | $0.47 | −$975 | 691,065 |
| Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | Feb 24 | Withheld — tax / exercise cost · F | −5,291 | $0.47 | −$2.5K | 1,941,293 |
| Dubois-Stringfellow Nathalie | SVP-CHIEF DEVELOPMENT OFFICER | Jan 22 | Withheld — tax / exercise cost · F | −36,676 | $0.40 | −$14.6K | 693,128 |
| Davis Gregory D | Head of Research & Technology | Jan 22 | Withheld — tax / exercise cost · F | −7,721 | $0.40 | −$3.08K | 191,062 |
| Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | Jan 22 | Withheld — tax / exercise cost · F | −102,950 | $0.40 | −$41K | 1,946,584 |
Loading...
